Zantac, Ranitidine Pulled From Market, Here Are FDA ’s Latest Cancer Concerns
New findings about N-Nitrosodimethylamine (NDMA) contamination of this type of heartburn medication led to the U.S. Food and Drug Administration's (FDA's) more drastic action. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 2, 2020 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

FDA Calls for Market Removal of Ranitidine FDA Calls for Market Removal of Ranitidine
The agency found through product testing that NDMA contamination in ranitidine, commonly known by the brand name Zantac, can develop over time when the product is stored above room temperature.News Alerts (Source: Medscape Pulmonary Medicine Headlines)
Source: Medscape Pulmonary Medicine Headlines - April 2, 2020 Category: Respiratory Medicine Tags: Gastroenterology News Alert Source Type: news

FDA calls for Zantac products to be pulled from market immediately
The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately, the agency announced on Wednesday. (Source: CNN.com - Health)
Source: CNN.com - Health - April 2, 2020 Category: Consumer Health News Source Type: news

FDA Requests Zantac Be Pulled From the Market
Six months after independent testing first raised the possibility that popular heartburn drug ranitidine (Zantac) might break down into the powerful carcinogen n-nitrosodimethylamine (NDMA), the FDA has asked for the removal of all ranitidine products from the market. (Source: WebMD Health)
Source: WebMD Health - April 2, 2020 Category: Consumer Health News Source Type: news

FDA calls for heartburn drug Zantac to be pulled from market immediately
The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately, the agency announced on Wednesday. (Source: CNN.com - Health)
Source: CNN.com - Health - April 1, 2020 Category: Consumer Health News Source Type: news

FDA Pulls Heartburn Drug Zantac From Market
WEDNESDAY, April 1, 2020 -- All versions of the heartburn drug Zantac (ranitidine) have been pulled from the U.S. market due to possible contamination with a probable human carcinogen, the U.S. Food and Drug Administration said Wednesday. This is... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2020 Category: Pharmaceuticals Source Type: news

FDA orders Zantac, other heartburn drugs removed from market due to NDMA contamination
The U.S. Food and Drug Administration ordered drugmakers to remove all prescription and over-the-counter products containing the agent ranitidine from the market immediately due to possible contamination. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 1, 2020 Category: Consumer Health News Source Type: news

FDA Calls For Heartburn Drug Zantac To Be Pulled From Market Immediately
(CNN) — The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately, the agency announced on Wednesday. The FDA noted that an ongoing investigation has determined that levels of a contaminant in the heartburn medications increase over time and when stored at higher-than-normal temperatures, poses a risk to public health. The contaminant, N-nitrosodimethylamine or NDMA, is a probable human carcinogen and the FDA has been investigating levels of it in ranitidine since the summer of 2019. &ld...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 1, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Zantac Source Type: news

All Ranitidine Products (Zantac): Press Release - FDA Requests Removal
The FDA announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 1, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

U.S. FDA moves to remove all versions of heartburn drug Zantac from market
Ranitidine will not be available for use in the U.S. after the FDA pulls all remaining prescription and over-the-counter products containing the ingredient found in the heartburn medication Zantac. (Source: CBC | Health)
Source: CBC | Health - April 1, 2020 Category: Consumer Health News Tags: News/Health Source Type: news

FDA Pulls Heartburn Drug Zantac From Market
WEDNESDAY, April 1, 2020 -- All versions of the heartburn drug Zantac (ranitidine) have been pulled from the U.S. market due to possible contamination with a probable cancer-causing chemical, the U.S. Food and Drug Administration said... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 1, 2020 Category: General Medicine Source Type: news

Class 2 medicines recall: Ranitidine 150mg and 300mg tablets
Medreich Plc is recalling all unexpired stock of ranitidine 150mg and 300mg tablets from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity N-nitrosod (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 3, 2020 Category: Drugs & Pharmacology Source Type: news

Granules India says 'voluntarily' recalling ranitidine tabs
Granules India has said that it has received multiple queries on the news item for recall of ranitidine by the drug firm. The company is in the process of recall from channel partners and the exact quantities are being estimated. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 13, 2020 Category: Pharmaceuticals Source Type: news

Three more heartburn drugs recalled over carcinogen fears
This week, the FDA announced recalls of Zantac generics made by Appco Pharma, Northwind and Mylan's non-ranitidine heartburn drug nizatdine. A California lab thinks heat triggers NDMA's creation. (Source: the Mail online | Health)
Source: the Mail online | Health - January 10, 2020 Category: Consumer Health News Source Type: news

Lab investigates heartburn drug ’s possible cancer link
The popular heartburn drug ranitidine, the generic form of Zantac, was linked to cancer in September, prompting some voluntary recalls of the drug and an investigation by the FDA. A lab in California has also been working to get to the bottom of its potential dangers. First on “CBS This Morning,” Dr. Jon LaPook has a look inside that lab. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - January 10, 2020 Category: Consumer Health News Source Type: news

Denton Pharma, Inc. dba Northwind Pharmaceuticals Voluntarily Recalls All Unexpired Lots of its Ranitidine Tablets and Ceases Distribution, Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity
Denton Pharma, Inc. dba Northwind Pharmaceuticals, an affiliate of Northwind Pharmaceuticals, LLC ( “Northwind”) today announced the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300mg, to the consumer level. The recall is in response to the manufacturer’s recall of all un (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 8, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Appco Pharma LLC Issues Voluntary Nationwide Recall of Ranitidine Hydrochloride Capsules 150 mg and 300 mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA)
Appco Pharma LLC (Appco) is voluntarily recalling all quantities and lots, within expiry, of Ranitidine Hydrochloride Capsules to the Consumer level. Ranitidine Hydrochloride Capsules are being recalled because of the presence or potential presence of N-nitrosodimethylamine (NDMA) (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 7, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Supply Disruption Alert Update – Ranitidine: all formulations
The Department of Health and Social Care (DHSC) has issued an update to its previous Supply Disruption Alert. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 23, 2019 Category: Drugs & Pharmacology Source Type: news

Glenmark Pharmaceutical Inc recalls ranitidine tablets in US
The tablets are being recalled because of the presence or potential presence of N-nitrosodimethylamine (NDMA) levels above the acceptable daily intake levels established by the United States Food and Drug Administration (USFDA), as per the company's announcement posted on the website of the US health regulator. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 22, 2019 Category: Pharmaceuticals Source Type: news

Glenmark Pharmaceuticals Inc., USA Voluntarily Recalls All Unexpired Lots of its Ranitidine Tablets and Ceases Distribution, Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity
Glenmark Pharmaceutical Inc., USA ( “Glenmark”) today announced the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300 mg, to the consumer level. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 18, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Class 2 Medicines Recall: Medley Pharma Limited, Ranitidine 150mg Tablets BP, PL 43870/0026, Ranitidine 300mg Tablets BP, PL 43870/0027
Medley Pharma Limited is... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 16, 2019 Category: Drugs & Pharmacology Source Type: news

Class 2 Medicines recall: Ranitidine 150mg Film-Coated Tablets, PL 20075/0063, Ranitidine 300mg Film-Coated Tablets, PL 20075/0064
Accord Healthcare are recalling all unexpired stock of the above products from pharmacies, retail stores and wholesalers as a precautionary measure, due to possible contamination with an impurityN-nit (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 5, 2019 Category: Drugs & Pharmacology Source Type: news

Doctors must stop prescribing Zantac until further notice, Department of Health says
The Department of Health and Social Care (DoHS) said stock of ranitidine said all versions of ranitidine had been quarantined. It has banned UK GPs from prescribing them. (Source: the Mail online | Health)
Source: the Mail online | Health - November 29, 2019 Category: Consumer Health News Source Type: news

Ranitidine: all formulations – Supply Disruption Alert – Update
The Department of Health and Social Care (DHSC) has updated their advice of a supply disruption of all formulations of ranitidine. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 28, 2019 Category: Drugs & Pharmacology Source Type: news

Zantac Recall: Does Ranitidine Cause Cancer?
Late September 2019, Valisure filed a Citizen Petition urging the FDA to recall ranitidine. Although several drug companies and major drug store chains quickly suspended sales of Zantac and its generic ranitidine voluntarily, the FDA did not issue... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 26, 2019 Category: General Medicine Source Type: news

From Licorice to Slippery Elm: What Works for GI Symptoms? From Licorice to Slippery Elm: What Works for GI Symptoms?
In the wake of recent concerns with ranitidine, Dr David Johnson shares the evidence (or lack thereof) for some popular alternative remedies that patients may turn to for upper GI diseases like reflux.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 22, 2019 Category: Gastroenterology Tags: Gastroenterology Commentary Source Type: news

Tanzania: Tanzania Agency Bans Ranitidine-Based Drugs
[East African] The state-run Tanzania Medicines and Medical Devices Authority (TMDA) has suspended the use of medicines containing the active pharmaceutical ingredient Ranitidine until further notice. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 22, 2019 Category: African Health Source Type: news

Class 2 medicines recall: Ranitidine 75mg tablets
OTC Concepts Ltd, Relconchem Ltd and Noumed Life Sciences Ltd are recalling all unexpired batches of the products mentioned in the MHRA alert from pharmacies and retail stores as a precautionary measu (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 21, 2019 Category: Drugs & Pharmacology Source Type: news

Tanzania: Tanzania Medicines and Medical Devices Authority Bans Heartburn Medications Over Cancer Risk
[Citizen] Dar es Salaam -All patients taking heartburn drugs with the active ingredient ranitidine must stop their course of treatment and report to a nearby health facility after authorities raised concern about the safety of the drugs. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 21, 2019 Category: African Health Source Type: news

Precision Dose Inc. Issues Voluntary Nationwide Recall of Ranitidine Oral Solution, USP 150 mg/10 mL Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity.
Precision Dose Inc. is voluntarily recalling 5 lots of Ranitidine Oral Solution, USP 150 mg/10 mL to the consumer level. Ranitidine Oral Solution, USP 150 mg/10 mL, is being recalled because of potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 20, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Class 2 medicines recall: ranitidine oral solution 30mg/ml and ranitidine 150mg tablets
Creo Pharma Limited and Tillomed Laboratories Limited are recalling all unexpired stock the products specified in the MHRA alert. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 19, 2019 Category: Drugs & Pharmacology Source Type: news

Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Ranitidine Hydrochloride 150mg and 300mg Capsules (Manufactured by Novitium Pharma LLC) Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA)
Golden State Medical Supply, Incorporated (GSMS, Inc) based upon a manufacturer ’s recall by Novitium Pharma LLC (Novitium), is voluntarily instituting a recall of all quantities and lots, within expiry, of Ranitidine HCl 150mg and 300mg Capsules to the consumer level because of potential presence of (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 18, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Amneal Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Ranitidine Tablets, USP, 150mg and 300mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL, Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity
Amneal Pharmaceuticals, LLC. Bridgewater, New Jersey is voluntarily recalling Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL to the consumer level. A listing of the recalled lots is identified below. Ranitidine Tablets, USP, 150 mg and 300 mg (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 12, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

American Health Packaging Issues Voluntary Nationwide Recall of Ranitidine Syrup (Ranitidine Oral Solution USP) 150 mg/10 mL Liquid Unit Dose Cups Due to the Detection of N-nitrosodimethylamine (NDMA) Impurity
American Health Packaging is voluntarily recalling eight lots of Ranitidine Syrup (Ranitidine Oral Solution USP) 150 mg/10 mL Liquid Unit Dose Cups to the consumer level due to the detection of trace amounts of an unexpected impurity found in the finished drug product. The impurity detected in the f (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 8, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Strides Pharma relaunches Ranitidine tablets in US
The company had suspended sales of its generic Ranitidine tablets after the USFDA found contamination in some Ranitidine tablets sold by various companies with potentially cancer causing impurities, NDMA. Strides said now the drug meets the limits prescribed by the US drug regulator. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 8, 2019 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Consumer Level Recall of 38 Lots of Ranitidine Tablets 150mg, Ranitidine Capsules 150mg, Ranitidine Capsules 300mg and Ranitidine Syrup 15mg/mL Due to the Detection of NDMA (Nitrosodimethylamine) Impurity
Aurobindo Pharma USA, Inc. is conducting a voluntary recall of 1 lot of Ranitidine Tablets 150mg to the retail level and 37 lots of Ranitidine Capsules 150mg, Ranitidine Capsules 300mg and Ranitidine Syrup 15mg/mL to the consumer level due to the detection of NDMA (Nitrosodimethylamine) Impurity in (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 7, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA says ranitidine no more dangerous than ‘smoked meats’
Since all the hoopla surrounding ranitidine began, the FDA has been cautious in giving a final word on how dangerous the levels of NDMA in the drug could be. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 5, 2019 Category: Pharmaceuticals Source Type: news

Ranitidine recall impacts Dr Reddy's P & L by Rs 40-crore
Dr Reddy's Laboratories which initiated a voluntary recall of its Ranitidine at the retail level for over-the-counter products and at the consumer level sold in the US due to confirmed contamination with N-Nitrosodimethylamine established by FDA following the ongoing investigation which reported carcinogenic impurity in the drug at low levels. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 4, 2019 Category: Pharmaceuticals Source Type: news

Our drug Ranitidine is safe: Strides Pharma
Ranitidine is a commonly prescribed medicine for countering acidity and is on the WHO ’s Model List of Essential Medicines. In India, a host of companies including GalxoSmithKline, JB Chemicals, Cadila Pharma, Zydus Cadila, Dr Reddy’s and Sun Pharmaceuticals sell over 180 versions of the drug. Strides Pharma is likely to resume drug sale, following the report. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 4, 2019 Category: Pharmaceuticals Source Type: news

Lannett Issues Voluntary Nationwide Recall of Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/ml due to an Elevated Level of the Unexpected Impurity, N-Nitrosodimethylamine (NDMA)
Lannett Company, Inc. today announced that it is voluntarily recalling all lots within expiry of Ranitidine Syrup (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 29, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Novitium Pharma Issues Voluntary National Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA)
Voluntarily recalling all quantities and lots, within expiry, of Ranitidine Hydrochloride Capsules in the US to the consumer level. Ranitidine Hydrochloride Capsules are being recalled because of potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 25, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Boots and Morrisons' own version of Zantac are recalled
Perrigo Company supplies ranitidine - the generic form of the branded heartburn drug - to both of the British retail giants. It announced the recall in an alert sent out by UK health chiefs today. (Source: the Mail online | Health)
Source: the Mail online | Health - October 25, 2019 Category: Consumer Health News Source Type: news

Class 2 Medicines recall: Ranitidine 150mg/10ml Oral Solution
Rosemont Pharmaceuticals Limited is recalling unexpired stock from pharmacies as a precautionary measure due to possible contamination with an impurity. Further information, details of the affected (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 25, 2019 Category: Drugs & Pharmacology Source Type: news

Dr Reddy ’s recalled all batches of heartburn drug from US
Ranitidine is commonly prescribed as an antacid and the NDMA impurity scandal had rocked Indian generic makers present in US who were one of the largest suppliers of the drug. After FDA ’s cautionary note, several Indian cos had to recall this product. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 25, 2019 Category: Pharmaceuticals Source Type: news

Dr. Reddy's is recalling some products used to treat heartburn
Dr. Reddy's Laboratories Ltd. and its subsidiaries issued a voluntary nationwide recall of its ranitidine medicines used to treat heartburn, the US Food and Drug Administration said on Wednesday. (Source: CNN.com - Health)
Source: CNN.com - Health - October 24, 2019 Category: Consumer Health News Source Type: news

U.S. FDA says carcinogen not found in alternatives of Zantac and its generics
U.S. retailers Walmart Inc, CVS Health Corp Walgreens Boots Alliance Inc and Rite Aid Corp have all removed Zantac off their shelves after some drugs containing its key ingredient ranitidine were found to have traces of the impurity, N-nitrosodimethylamine (NDMA). (Source: Reuters: Health)
Source: Reuters: Health - October 24, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Perrigo Company plc Issues Voluntary Worldwide Recall of Ranitidine Due to Possible Presence of Impurity, N-nitrosodimethylamine (NDMA) Impurity in the Product
As a precautionary measure, Perrigo Company plc announced today that it has initiated a voluntary, worldwide product recall to the retail customer level of ranitidine (all pack sizes). The recall is being taken due to possible presence of a nitrosamine impurity called N-nitrosodimethylamine (NDMA). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 24, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Dr. Reddy ’s Confirms its Voluntary Nationwide Recall of All Ranitidine Products in the U.S. Market
Nationwide recall on October 1, 2019, (at the retail level for over-the-counter products and at the consumer level for prescription products) of all of its ranitidine medications sold in US due to confirmed contamination with N-Nitrosodimethylamine (NDMA) above levels established by the FDA (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Batches of Strides' Ranitidine tablets now available for sale in Australia
Out of the 135 batches of Ranitidine which were tested by TGA, 109 batches were found to have an NDMA level at or above the acceptable limit of 0.3 ppm. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 23, 2019 Category: Pharmaceuticals Source Type: news

Dr Reddy's recalls all its ranitidine products in US
NDMA is classified as a probable human carcinogen based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 23, 2019 Category: Pharmaceuticals Source Type: news